Johnson & Johnson said on Wednesday its combination drug helped increase the duration of no progress in a type of non small-cell lung cancer in patients.
said on Wednesday its combination drug helped increase the duration of no progress in a type of non small-cell lung cancer in patients.
The therapy met the main goals of the study that tested a combination of antibody treatment Rybrevant and experimental drug lazertinib against chemotherapy in patients with a more common mutation in EGFR protein that causes rapid cell growth. J&J's therapy was tested in patients in whom the disease progressed even after they were treated with AstraZeneca's Tagrisso.approval in 2021 for only 2-3% of non small-cell lung cancer patients - a small subset that had a specific type of mutation in EGFR protein.
J&J is also testing its combination treatment in a head-to-head study with Tagrisso, and expects data from the trial by the end of this year. If successful, the company expects the therapy to become a first-line treatment for NSCLC patients with the mutation.Reporting by Leroy Leo in Bengaluru; Editing by Pooja Desai and Shinjini Ganguli
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Dow drops 88 points on losses for shares of Merck, Johnson & JohnsonShares of Merck and Johnson & Johnson are trading lower Wednesday morning, sending the Dow Jones Industrial Average into negative territory. Shares of Merck...
続きを読む »
Wednesday's ChildStories about our Wednesday's Child adoption program, which airs each Wednesday night.
続きを読む »
DCFS staff holding ‘safety rally’ Wednesday to improve working conditions at Jane Edna officeMembers of the American Federation of State, County and Municipal Employees Local 1746 union, which represents about 500 social workers, will hold a “safety rally” at 4 p.m. on Wednesday in front of the Jane Edna Hunter Social Services office building to call for better working conditions.
続きを読む »
Sports on TV for Wednesday, September 6(All times Eastern) Schedule subject to change and/or blackouts Wednesday, September 6 FS2 — AFL: Melbourne at Collingwood
続きを読む »
Dallas under heat advisory through Wednesday but may have ‘fall-like weather’ next weekDallas-Fort Worth was under a heat advisory through Wednesday night but fall-like temperatures expected next week.
続きを読む »
ERCOT issues Weather Watch for Wednesday-Friday as scorching summer heat continuesThe Electrical Reliability Council of Texas issued a Weather Watch for Wednesday thru Friday due to forecasted higher temperatures, higher electrical demand, and the potential for lower reserves.
続きを読む »